Literature DB >> 21969630

The in vivo invasion assay: preparation and handling of collection needles.

Jeffrey Wyckoff, Bojana Gligorijevic, David Entenberg, Jeffrey Segall, John Condeelis.   

Abstract

Analysis of the individual steps in metastasis is crucial if insights at the molecular level are to be linked to the cell biology of cancer. A technical hurdle to achieving the analysis of the individual steps of metastasis is the fact that, at the gross level, tumors are heterogeneous in both animal models and patients. Human primary tumors show extensive variation in all properties ranging from growth and morphology of the tumor through tumor-cell density in the blood and formation and growth of metastases. Methods capable of the direct visualization and analysis of tumor-cell behavior at single-cell resolution in vivo have become crucial in advancing the understanding of mechanisms of metastasis, the definition of microenvironment, and the markers related to both. High-resolution multiphoton imaging of tumors in vivo is a valuable tool in this regard. Because tumor cells have been found to be attracted to blood vessels, the in vivo invasion assay was developed to analyze which factors may stimulate invasion of these cells into the vessels. This protocol describes the preparation and handling of collection needles for the assay. A set of 33-gauge needles is used to create artificial or surrogate blood vessels that are injected into tumors, using a special holding device attached to a micromanipulator to stabilize the needle positions during and after insertion into the anesthetized animal. The needles are filled with Matrigel and various growth factors to determine which of these factors may influence the invading tumor cells.

Entities:  

Mesh:

Year:  2011        PMID: 21969630      PMCID: PMC4000024          DOI: 10.1101/pdb.prot065912

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  2 in total

1.  High-resolution multiphoton imaging of tumors in vivo.

Authors:  Jeffrey Wyckoff; Bojana Gligorijevic; David Entenberg; Jeffrey Segall; John Condeelis
Journal:  Cold Spring Harb Protoc       Date:  2011-10-01

2.  A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors.

Authors:  Jeffrey Wyckoff; Weigang Wang; Elaine Y Lin; Yarong Wang; Fiona Pixley; E Richard Stanley; Thomas Graf; Jeffrey W Pollard; Jeffrey Segall; John Condeelis
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

  2 in total
  5 in total

Review 1.  Signatures of breast cancer metastasis at a glance.

Authors:  George S Karagiannis; Sumanta Goswami; Joan G Jones; Maja H Oktay; John S Condeelis
Journal:  J Cell Sci       Date:  2016-04-15       Impact factor: 5.285

2.  High-resolution multiphoton imaging of tumors in vivo.

Authors:  Jeffrey Wyckoff; Bojana Gligorijevic; David Entenberg; Jeffrey Segall; John Condeelis
Journal:  Cold Spring Harb Protoc       Date:  2011-10-01

3.  Combining TMEM Doorway Score and MenaCalc Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2- Breast Cancer Patients.

Authors:  Xianjun Ye; Maja H Oktay; Xiaonan Xue; Thomas E Rohan; Paula S Ginter; Timothy D'Alfonso; Elizabeth N Kornaga; Don G Morris; David Entenberg; John S Condeelis
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

4.  Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres.

Authors:  Anjana Jain; Martha Betancur; Gaurangkumar D Patel; Chandra M Valmikinathan; Vivek J Mukhatyar; Ajit Vakharia; S Balakrishna Pai; Barunashish Brahma; Tobey J MacDonald; Ravi V Bellamkonda
Journal:  Nat Mater       Date:  2014-02-16       Impact factor: 43.841

5.  Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway.

Authors:  E Leung; A Xue; Y Wang; P Rougerie; V P Sharma; R Eddy; D Cox; J Condeelis
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.